PROVECTUS BIOPHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $589.2K
Liabilities Breakdown FY2020
Total Liabilities: $30.8M
Asset Breakdown
Total Assets: $589.2K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $97.2K | 16.5% |
| Accounts Receivable | $3.9K | 0.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $44.7K | 7.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $443.3K | 75.2% |
Liabilities Breakdown
Total Liabilities: $30.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $956.9K | 3.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $29.8M | 96.9% |